secwatch.observer — SEC 8-K summary
======================================

Issuer:     Protagenic Therapeutics, Inc.new (PTIX)
CIK:        0001022899
Form:       8-K
Filed at:   2025-04-18T23:59:59+00:00
Accession:  0001641172-25-005368
Event type: other_material
Sentiment:  neutral
Materiality: 0.60
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

Protagenic shareholders approve reverse stock split at ratio 1:10 to 1:20
-------------------------------------------------------------------------

- Special Meeting held April 18, 2025; 4,049,963 shares present out of 7,241,443 entitled.
- Reverse split proposal passed: 3,560,865 for, 333,824 against, 155,274 abstain.
- Board authorized to choose exact ratio between 1:10 and 1:20 and timing before Jan 31, 2026.
- Adjournment proposal also approved: 3,552,086 for, 336,677 against, 161,200 abstain.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1022899/000164117225005368/0001641172-25-005368-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1022899/000164117225005368/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001641172-25-005368

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer